1887

Microbial Genomics logo

Volume 10, Issue 11

Genome and antibiotic resistance characteristics of clinical isolates in Fujian Province, Southeast China, 2005–2019 Open Access

Abstract

Shigellosis is a serious public health issue in many developing countries. The emergence of multidrug-resistant (MDR) isolates has deepened the treatment difficulty and health burden of shigellosis. China is the largest developing country in the world, but so far, the genome of MDR isolates has not been well characterized. In this study, 60 clinical isolates of spp. in Fujian Province, southeast China, from 2005 to 2019 were characterized for drug resistance phenotype, whole-genome sequencing and bioinformatics analysis. The results showed that the MDR rate of isolates was 100%, among which the resistance rates of cefotaxime, ciprofloxacin and azithromycin were 36.67, 21.67 and 10.00 %, respectively. The positive rate of extended-spectrum beta-lactamase (ESBL)-producing strains was 23.33%. The resistance profiles of and to some antimicrobials differed. The MDR isolates carried multiple antimicrobial resistance genes, among which and mediated ESBL resistance ‘’ (type I) and ‘’ (type II) were the most common genetic environments around the genes, and plasmids containing these structures included IncFII, IncI1, IncI2 and IncN. The double gene mutation pattern of A and C resulted in a significant decrease in the sensitivity of to ciprofloxacin. The overall resistance phenotype and genotype concordance rate was 88.50%, and the sensitivity and specificity of the genotype antimicrobial susceptibility test (AST) were 93.35 and 82.53 %, respectively. However, inconsistency occurred between phenotypic and genotype profiles for a few antibiotics. Phylogenomic investigation with core genome multi-locus sequence typing (cgMLST) and SNPs were used to characterize the endemic transmission of these infections in Fujian and their evolutionary origin within the global context. For , Fujian isolates were all limited to PG3 and could be divided into three phylogenetic clusters. The ciprofloxacin-resistant strains were mainly F2a and FXv and assigned to the three clusters with different quinolone resistance-determining region mutation patterns. For , most Fujian strains belonged to Lineage III with genotype 3.7.6, except three isolates of Lineage I with genotype 1.3. The strains carrying the genes were dispersed, indicating different origins of gene acquisition. Most of the circulating isolates in Fujian Province were not related to major international outbreak lineages and were only endemic to the country. In conclusion, multi-drug resistance of isolates in Fujian Province was serious, and genome-based laboratory surveillance will be crucial to the clinical treatment and public health measures for shigellosis.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): antibiotics , multidrug resistance , phylogenetic analysis , Shigella and whole-genome sequencing
Funding
This study was supported by the:
  • Fujian Provincial Health Technology Project (Award 2021CXA024)
    • Principle Award Recipient: JinsongYang
  • Natural Science Foundation of Fujian Province (Award 2022J01399)
    • Principle Award Recipient: JinsongYang
© 2024 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.001325
2024-11-20
2024-12-09
Loading full text...

Full text loading...

/deliver/fulltext/mgen/10/11/mgen001325.html?itemId=/content/journal/mgen/10.1099/mgen.0.001325&mimeType=html&fmt=ahah

References

  1. Kotloff KL, Riddle MS, Platts-Mills JA, Pavlinac P, Zaidi AKM. Shigellosis. Lancet 2018; 391:801–812 [View Article] [PubMed]
     [Google Scholar]
  2. Rolfo F, Marin GH, Silberman M, Pattin J, Giugnio S et al. Epidemiological study of shigellosis in an urban area of Argentina. J Infect Dev Ctries 2012; 6:324–328 [View Article] [PubMed]
     [Google Scholar]
  3. Gu B, Cao Y, Pan S, Zhuang L, Yu R et al. Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of Shigella between Europe-America and Asia-Africa from 1998 to 2009. Int J Antimicrob Agents 2012; 40:9–17 [View Article] [PubMed]
     [Google Scholar]
  4. Hawkey J, Paranagama K, Baker KS, Bengtsson RJ, Weill F-X et al. Global population structure and genotyping framework for genomic surveillance of the major dysentery pathogen, Shigella sonnei. Nat Commun 2021; 12:2684 [View Article] [PubMed]
     [Google Scholar]
  5. Thompson CN, Duy PT, Baker S. The rising dominance of Shigella sonnei: an intercontinental shift in the etiology of bacillary dysentery. PLoS Negl Trop Dis 2015; 9:e0003708 [View Article] [PubMed]
     [Google Scholar]
  6. Torraca V, Holt K, Mostowy S. Shigella sonnei. Trends Microbiol 2020; 28:696–697 [View Article] [PubMed]
     [Google Scholar]
  7. Chang Z, Zhang J, Ran L, Sun J, Liu F et al. The changing epidemiology of bacillary dysentery and characteristics of antimicrobial resistance of Shigella isolated in China from 2004-2014. BMC Infect Dis 2016; 16:685 [View Article] [PubMed]
     [Google Scholar]
  8. Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD, Swerdlow DL et al. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ 1999; 77:651–666 [PubMed]
     [Google Scholar]
  9. Salam MA, Bennish ML. Antimicrobial therapy for shigellosis. Rev Infect Dis 1991; 13:S332–S341 [View Article] [PubMed]
     [Google Scholar]
  10. The selection and use of essential medicines. In World Health Organ Tech Rep Ser. 5(994):Vii-Xv 2015 pp 1–546
     [Google Scholar]
  11. Yassine I, Rafei R, Pardos de la Gandara M, Osman M, Fabre L et al. Genomic analysis of Shigella isolates from Lebanon reveals marked genetic diversity and antimicrobial resistance. Microb Genom 2023; 9:001157 [View Article] [PubMed]
     [Google Scholar]
  12. Muthuirulandi Sethuvel DP, Mutreja A, Pragasam AK, Vasudevan K, Murugan D et al. Phylogenetic and evolutionary analysis reveals the recent dominance of ciprofloxacin-resistant Shigella sonnei and local persistence of S. flexneri clones in India. mSphere 2020; 5:e00569-20 [View Article] [PubMed]
     [Google Scholar]
  13. Mandal J, Mondal N, Mahadevan S, Parija SC. Emergence of resistance to third-generation cephalosporin in Shigella--a case report. J Trop Pediatr 2010; 56:278–279 [View Article] [PubMed]
     [Google Scholar]
  14. Bowen A, Hurd J, Hoover C, Khachadourian Y, Traphagen E et al. Importation and domestic transmission of shigella sonnei resistant to ciprofloxacin - United States. MMWR Morb Mortal Wkly Rep 2014; 64:318–320
     [Google Scholar]
  15. Fischer N, Maex M, Mattheus W, Van den Bossche A, Van Cauteren D et al. Genomic epidemiology of persistently circulating MDR Shigella sonnei strains associated with men who have sex with men (MSM) in Belgium (2013-19). J Antimicrob Chemother 2021; 77:89–97 [View Article] [PubMed]
     [Google Scholar]
  16. Bradley P, Gordon NC, Walker TM, Dunn L, Heys S et al. Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis. Nat Commun 2015; 6:10063 [View Article] [PubMed]
     [Google Scholar]
  17. Katiyar A, Sharma P, Dahiya S, Singh H, Kapil A et al. Genomic profiling of antimicrobial resistance genes in clinical isolates of Salmonella Typhi from patients infected with Typhoid fever in India. Sci Rep 2020; 10:8299 [View Article] [PubMed]
     [Google Scholar]
  18. Metcalf BJ, Chochua S, Gertz RE Jr, Li Z, Walker H et al. Using whole genome sequencing to identify resistance determinants and predict antimicrobial resistance phenotypes for year 2015 invasive pneumococcal disease isolates recovered in the United States. Clin Microbiol Infect 2016; 22:1002 [View Article] [PubMed]
     [Google Scholar]
  19. Pfaller MA. Molecular approaches to diagnosing and managing infectious diseases: practicality and costs. Emerg Infect Dis 2001; 7:312–318 [View Article] [PubMed]
     [Google Scholar]
  20. Tyson GH, McDermott PF, Li C, Chen Y, Tadesse DA et al. WGS accurately predicts antimicrobial resistance in Escherichia coli. J Antimicrob Chemother 2015; 70:2763–2769 [View Article] [PubMed]
     [Google Scholar]
  21. Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S et al. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 2012; 67:2640–2644 [View Article] [PubMed]
     [Google Scholar]
  22. Stubberfield E, AbuOun M, Sayers E, O’Connor HM, Card RM et al. Use of whole genome sequencing of commensal Escherichia coli in pigs for antimicrobial resistance surveillance, United Kingdom, 2018. Euro Surveill 2019; 24:1900136 [View Article] [PubMed]
     [Google Scholar]
  23. Bortolaia V, Kaas RS, Ruppe E, Roberts MC, Schwarz S et al. ResFinder 4.0 for predictions of phenotypes from genotypes. J Antimicrob Chemother 2020; 75:3491–3500 [View Article] [PubMed]
     [Google Scholar]
  24. Nataro JP, Bopp CA, Fields PI, Kaper JB. Escherichia, Shigella, and Salmonella John Wiley & Sons, Ltd; 2003
     [Google Scholar]
  25. CLSI Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st Wayne, PA; 2021
     [Google Scholar]
  26. Tack B, Phoba M-F, Thong P, Lompo P, Hupko C et al. Epidemiological cut-off value and antibiotic susceptibility test methods for azithromycin in a collection of multi-country invasive non-typhoidal Salmonella. Clin Microbiol Infect 2022; 28:1615–1623 [View Article] [PubMed]
     [Google Scholar]
  27. Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 2012; 19:455–477 [View Article] [PubMed]
     [Google Scholar]
  28. Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics 2014; 30:2068–2069 [View Article] [PubMed]
     [Google Scholar]
  29. Koren S, Walenz BP, Berlin K, Miller JR, Bergman NH et al. Canu: scalable and accurate long-read assembly via adaptive k-mer weighting and repeat separation. Genome Res 2017; 27:722–736 [View Article] [PubMed]
     [Google Scholar]
  30. Walker BJ, Abeel T, Shea T, Priest M, Abouelliel A et al. Pilon: an integrated tool for comprehensive microbial variant detection and genome assembly improvement. PLoS One 2014; 9:e112963 [View Article] [PubMed]
     [Google Scholar]
  31. Yassine I, Hansen EE, Lefèvre S, Ruckly C, Carle I et al. ShigaPass: an in silico tool predicting Shigella serotypes from whole-genome sequencing assemblies. Microb Genom 2023; 9: [View Article]
     [Google Scholar]
  32. Yassine I, Lefèvre S, Hansen EE, Ruckly C, Carle I et al. Population structure analysis and laboratory monitoring of Shigella by core-genome multilocus sequence typing. Nat Commun 2022; 13:551 [View Article] [PubMed]
     [Google Scholar]
  33. Page AJ, Cummins CA, Hunt M, Wong VK, Reuter S et al. Roary: rapid large-scale prokaryote pan genome analysis. Bioinformatics 2015; 31:3691–3693 [View Article] [PubMed]
     [Google Scholar]
  34. Croucher NJ, Page AJ, Connor TR, Delaney AJ, Keane JA et al. Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins. Nucleic Acids Res 2015; 43:e15 [View Article] [PubMed]
     [Google Scholar]
  35. Lefèvre S, Njamkepo E, Feldman S, Ruckly C, Carle I et al. Rapid emergence of extensively drug-resistant Shigella sonnei in France. Nat Commun 2023; 14:462 [View Article] [PubMed]
     [Google Scholar]
  36. Salleh MZ, Nik Zuraina NMN, Hajissa K, Ilias MI, Banga Singh KK et al. Prevalence of multidrug-resistant and extended-spectrum beta-lactamase-producing Shigella species in Asia: a systematic review and meta-analysis. Antibiotics 2022; 11:1653 [View Article] [PubMed]
     [Google Scholar]
  37. Liu G, Qian H, Tang B, Chen Y, Kang H et al. Prevalence and characterisation of third-generation cephalosporin-resistant Shigella flexneri isolates from Jiangsu Province, China, 2013-2015. J Glob Antimicrob Resist 2018; 15:283–287 [View Article] [PubMed]
     [Google Scholar]
  38. Tansarli GS, Poulikakos P, Kapaskelis A, Falagas ME. Proportion of extended-spectrum β-lactamase (ESBL)-producing isolates among Enterobacteriaceae in Africa: evaluation of the evidence--systematic review. J Antimicrob Chemother 2014; 69:1177–1184 [View Article] [PubMed]
     [Google Scholar]
  39. Farajzadeh Sheikh A, Moradi Bandbal M, Saki M. Emergence of multidrug-resistant Shigella species harboring extended-spectrum beta-lactamase genes in pediatric patients with diarrhea from southwest of Iran. Mol Biol Rep 2020; 47:7097–7106 [View Article] [PubMed]
     [Google Scholar]
  40. Moreno-Mingorance A, Mir-Cros A, Goterris L, Rodriguez-Garrido V, Sulleiro E et al. Increasing trend of antimicrobial resistance in Shigella associated with MSM transmission in Barcelona, 2020-21: outbreak of XRD Shigella sonnei and dissemination of ESBL-producing Shigella flexneri. J Antimicrob Chemother 2023; 78:975–982 [View Article] [PubMed]
     [Google Scholar]
  41. Kong M, Liu C, Xu Y, Wang J, Jin D. Concordance between genotypic and phenotypic drug-resistant profiles of shigella isolates from Taiyuan city. Microbiol Spectr 2005; 11:e0011923 [View Article]
     [Google Scholar]
  42. Ye C, Lan R, Xia S, Zhang J, Sun Q et al. Emergence of a new multidrug-resistant serotype X variant in an epidemic clone of Shigella flexneri. J Clin Microbiol 2010; 48:419–426 [View Article] [PubMed]
     [Google Scholar]
  43. Gu B, Zhou M, Ke X, Pan S, Cao Y et al. Comparison of resistance to third-generation cephalosporins in Shigella between Europe-America and Asia-Africa from 1998 to 2012. Epidemiol Infect 2015; 143:2687–2699 [View Article] [PubMed]
     [Google Scholar]
  44. Nisa I, Qasim M, Yasin N, Ullah R, Ali A. Shigella flexneri: an emerging pathogen. Folia Microbiol 2020; 65:275–291 [View Article] [PubMed]
     [Google Scholar]
  45. Zhu Y-G, Johnson TA, Su J-Q, Qiao M, Guo G-X et al. Diverse and abundant antibiotic resistance genes in Chinese swine farms. Proc Natl Acad Sci U S A 2013; 110:3435–3440 [View Article] [PubMed]
     [Google Scholar]
  46. Wang J, Wang P, Wang X, Zheng Y, Xiao Y. Use and prescription of antibiotics in primary health care settings in China. JAMA Intern Med 2014; 174:1914–1920 [View Article] [PubMed]
     [Google Scholar]
  47. Lin H, Dyar OJ, Rosales-Klintz S, Zhang J, Tomson G et al. Trends and patterns of antibiotic consumption in Shanghai municipality, China: a 6 year surveillance with sales records, 2009-14. J Antimicrob Chemother 2016; 71:1723–1729 [View Article] [PubMed]
     [Google Scholar]
  48. Baker KS, Jauneikaite E, Hopkins KL, Lo SW, Sánchez-Busó L et al. Genomics for public health and international surveillance of antimicrobial resistance. Lancet Microbe 2023; 4:e1047–e1055 [View Article] [PubMed]
     [Google Scholar]
  49. Kim S, Park AK, Kim JS, Park J, Shin E et al. The role of international travellers in the spread of CTX-M-15-producing Shigella sonnei in the Republic of Korea. J Glob Antimicrob Resist 2019; 18:298–303 [View Article] [PubMed]
     [Google Scholar]
  50. Zhang W, Zhou CL, Hu Y, Lin L, Li J et al. Dissemination of multiple drug-resistant Shigella flexneri 2a isolates among pediatric outpatients in Urumqi, China. Foodborne Pathog Dis 2022; 19:522–528 [View Article] [PubMed]
     [Google Scholar]
  51. Gu B, Qin T-T, Fan W-T, Bi R-R, Chen Y et al. Novel mutations in gyrA and parC among Shigella sonnei strains from Jiangsu Province of China, 2002-2011. Int J Infect Dis 2017; 59:44–49 [View Article] [PubMed]
     [Google Scholar]
  52. Yu X, Zhang D, Song Q. Profiles of gyrA mutations and plasmid-mediated quinolone resistance genes in Shigella isolates with different levels of fluoroquinolone susceptibility. Infect Drug Resist 2020; 13:2285–2290 [View Article] [PubMed]
     [Google Scholar]
  53. Zhu Z, Cao M, Zhou X, Li B, Zhang J. Epidemic characterization and molecular genotyping of Shigella flexneri isolated from calves with diarrhea in Northwest China. Antimicrob Resist Infect Control 2017; 6:92 [View Article] [PubMed]
     [Google Scholar]
  54. Liu L, Zhang X, Yang S, Zhai Y, Liu W et al. Differential CTX-M expression from a conserved promoter: role of promoter-associated spacer sequences downstream of the blaCTX-M Regulon. J Mol Microbiol Biotechnol 2016; 26:284–290 [View Article] [PubMed]
     [Google Scholar]
  55. Connor TR, Barker CR, Baker KS, Weill F-X, Talukder KA et al. Species-wide whole genome sequencing reveals historical global spread and recent local persistence in Shigella flexneri. Elife 2015; 4:e07335 [View Article] [PubMed]
     [Google Scholar]
  56. Qiu S, Liu K, Yang C, Xiang Y, Min K et al. A Shigella sonnei clone with extensive drug resistance associated with waterborne outbreaks in China. Nat Commun 2022; 13:7365 [View Article] [PubMed]
     [Google Scholar]
  57. Locke RK, Greig DR, Jenkins C, Dallman TJ, Cowley LA. Acquisition and loss of CTX-M plasmids in Shigella species associated with MSM transmission in the UK. Microb Genom 2021; 7:000644 [View Article] [PubMed]
     [Google Scholar]
  58. Gaudreau C, Bernaquez I, Pilon PA, Goyette A, Yared N et al. Clinical and genomic investigation of an international ceftriaxone- and azithromycin-resistant Shigella sonnei cluster among men who have sex with men, Montréal, Canada 2017-2019. Microbiol Spectr 2022; 10:e0233721 [View Article] [PubMed]
     [Google Scholar]
  59. Ingle DJ, Andersson P, Valcanis M, Barnden J, da Silva AG et al. Prolonged outbreak of multidrug-resistant Shigella sonnei harboring bla(CTX-M-27) in Victoria, Australia. Antimicrob Agents Chemother 2020; 64: [View Article]
     [Google Scholar]
/content/journal/mgen/10.1099/mgen.0.001325
Loading
Genome and antibiotic resistance characteristics of Shigella clinical isolates in Fujian Province, Southeast China, 2005–2019
M Gen 10, 001325 (2024); https://doi.org/10.1099/mgen.0.001325
/content/journal/mgen/10.1099/mgen.0.001325
/content/journal/mgen/10.1099/mgen.0.001325
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Supplementary material 2

PDF

Supplementary material 3

EXCEL

Supplementary material 4

EXCEL

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error